Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wittes

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Statistics in Medicine|April 1, 1989
Surrogate endpoints in clinical trials: cardiovascular diseasesJ Wittes, E Lakatos, J Probstfield
JAMA|October 14, 1988
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarctionS Yusuf, J Wittes, L Friedman
American Heart Journal|March 29, 2001
Terms of reference for Data and Safety Monitoring CommitteesM Packer, J Wittes, D Stump
Statistics in Medicine|February 28, 1992
The use of subjective rankings in clinical trials with an application to cardiovascular diseaseD Follmann, J Wittes, J A Cutler
Circulation|January 1, 1986
Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methodsS Yusuf, J Wittes, K Bailey, et al.
Statistics in Medicine|July 15, 1993
Analysis as-randomized and the problem of non-adherence: an example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass SurgeryP Peduzzi, J Wittes, K Detre, et al.
Statistics in Medicine|March 30, 1997
Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP)E Brittain, J Palensky, J Blood, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1991
Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery studyP Peduzzi, K Detre, J Wittes, et al.
JAMA|July 3, 1991
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trialsS Yusuf, J Wittes, J Probstfield, et al.
Statistics in Medicine|December 28, 1999
Internal pilot studies I: type I error rate of the naive t-testJ Wittes, O Schabenberger, D Zucker, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Statistics in Medicine|April 1, 1989
Surrogate endpoints in clinical trials: cardiovascular diseasesJ Wittes, E Lakatos, J Probstfield
JAMA|October 14, 1988
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarctionS Yusuf, J Wittes, L Friedman
American Heart Journal|March 29, 2001
Terms of reference for Data and Safety Monitoring CommitteesM Packer, J Wittes, D Stump
Statistics in Medicine|February 28, 1992
The use of subjective rankings in clinical trials with an application to cardiovascular diseaseD Follmann, J Wittes, J A Cutler
Circulation|January 1, 1986
Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methodsS Yusuf, J Wittes, K Bailey, et al.
Statistics in Medicine|July 15, 1993
Analysis as-randomized and the problem of non-adherence: an example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass SurgeryP Peduzzi, J Wittes, K Detre, et al.
Statistics in Medicine|March 30, 1997
Blinded subjective rankings as a method of assessing treatment effect: a large sample example from the Systolic Hypertension in the Elderly Program (SHEP)E Brittain, J Palensky, J Blood, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1991
Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery studyP Peduzzi, K Detre, J Wittes, et al.
JAMA|July 3, 1991
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trialsS Yusuf, J Wittes, J Probstfield, et al.
Statistics in Medicine|December 28, 1999
Internal pilot studies I: type I error rate of the naive t-testJ Wittes, O Schabenberger, D Zucker, et al.
Pageof 6